Intraductal Papillary Mucinous Neoplasm, Pancreas Cyst
Conditions
Keywords
MRI
Brief summary
This study aims to establish abbreviated PB MRI protocol for patients on regular imaging follow-up for pancreas cystic neoplasm.
Interventions
DIAGNOSTIC_TESTAbbreviated PB MRI
Abbreviated PB MRI which targets table time of 10 minutes. For MRI acquisition, standard dose of commercially available MR contrast agent (Gadovist, Bayer, Germany) is used on weight-based dosing (0.1mmol/kg).
Sponsors
Seoul National University Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* on follow-up for pancreas intraductal mucinous neoplasm * OR incidentally detected pancreas cyst (equal to or larger than 1cm) * AND scheduled for CECT or has CECT within a months * AND sign informed consent
Exclusion criteria
* Any absolute or relative contra-indication for contrast-enhanced MRI * No pancreas cystic neoplasm * History of pancreatectomy * History of any procedure for pancreatic cyst (ablation, aspiration...) in a year * Hemosiderosis * Suspicion of acute pancreatitis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Table time of Abbreviated PB MRI | 1 day after PB MRI acquisition | total scan time |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| In room time of Abbreviated PB MRI | 1 day after PB MRI acquisition | time spent in room by participants (difference between walk-in and walk-out times) |
| Diagnostic confidence | 6 months after participants enrollment | subjective diagnostic confidence for pancreas cystic neoplasm on five point scale |
| Image quality | 6 months after participants enrollment | overall image quality of Abbreviated PB MRI |
| Requirement for re-examination | 6 months after participants enrollment | clinical need for re-examination due to suboptimal image quality |
Countries
South Korea
Outcome results
None listed